Marks L - Search Results

1

Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review.

Yamada Y, Ukimura O, Kaneko M, Matsugasumi T, Fujihara A, Vourganti S, Marks L, Sidana A, Klotz L, Salomon G, de la Rosette J. Yamada Y, et al. Among authors: marks l. World J Urol. 2021 Mar;39(3):677-686. doi: 10.1007/s00345-020-03366-x. Epub 2020 Jul 29. World J Urol. 2021. PMID: 32728885 Review.

2

Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.

Marks LS, Treiger B, Dorey FJ, Fu YS, deKernion JB. Marks LS, et al. Urology. 1994 Oct;44(4):486-92. doi: 10.1016/s0090-4295(94)80044-8. Urology. 1994. PMID: 7524234

3

Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.

Marks LS, Partin AW, Gormley GJ, Dorey FJ, Shery ED, Garris JB, Subong EN, Stoner E, deKernion JB. Marks LS, et al. J Urol. 1997 Jun;157(6):2171-8. J Urol. 1997. PMID: 9146609 Clinical Trial.

4

Long-term effects of finasteride on prostate tissue composition.

Marks LS, Partin AW, Dorey FJ, Gormley GJ, Epstein JI, Garris JB, Macairan ML, Shery ED, Santos PB, Stoner E, deKernion JB. Marks LS, et al. Urology. 1999 Mar;53(3):574-80. Urology. 1999. PMID: 10096387 Clinical Trial.

5

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.

Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, deKernion JB. Marks LS, et al. J Urol. 2000 May;163(5):1451-6. J Urol. 2000. PMID: 10751856 Clinical Trial.

6

The role of prostate needle biopsy in evaluation of chemopreventive agents.

Marks LS, Epstein JI, Partin AW. Marks LS, et al. Urology. 2001 Apr;57(4 Suppl 1):191-3. doi: 10.1016/s0090-4295(00)00972-9. Urology. 2001. PMID: 11295625

7

Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue.

Marks LS, Kojima M, Demarzo A, Heber D, Bostwick DG, Qian J, Dorey FJ, Veltri RW, Mohler JL, Partin AW. Marks LS, et al. Urology. 2004 Oct;64(4):765-71. doi: 10.1016/j.urology.2004.05.047. Urology. 2004. PMID: 15491717

8

The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations.

Marks LS, Andriole GL, Fitzpatrick JM, Schulman CC, Roehrborn CG. Marks LS, et al. J Urol. 2006 Sep;176(3):868-74. doi: 10.1016/j.juro.2006.04.024. J Urol. 2006. PMID: 16890642 Review.

9

Prostatic tissue testosterone and dihydrotestosterone in African-American and white men.

Marks LS, Hess DL, Dorey FJ, Macairan ML. Marks LS, et al. Urology. 2006 Aug;68(2):337-41. doi: 10.1016/j.urology.2006.03.013. Urology. 2006. PMID: 16904448

10

Prevention of benign prostatic hyperplasia disease.

Marks LS, Roehrborn CG, Andriole GL. Marks LS, et al. J Urol. 2006 Oct;176(4 Pt 1):1299-306. doi: 10.1016/j.juro.2006.06.022. J Urol. 2006. PMID: 16952616 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,419 results

Search Page

Filters